Analyst Ratings For Biopharmx Corp (NASDAQ:BPMX)
Today, HC Wainwright reiterated its Buy rating on Biopharmx Corp (NASDAQ:BPMX) with a price target of $3.00.
There are 3 buy ratings on the stock.
The current consensus rating on Biopharmx Corp (NASDAQ:BPMX) is Buy (Score: 3.00) with a consensus target price of $2.50 per share, a potential 822.51% upside.
Some recent analyst ratings include
- 9/19/2017-HC Wainwright Reiterated Rating of Buy.
- 9/13/2017-Maxim Group Reiterated Rating of Buy .
Recent Trading Activity for Biopharmx Corp (NASDAQ:BPMX)
Shares of Biopharmx Corp closed the previous trading session at with shares trading hands.